IRIS

Sfoglia per Rivista  VACCINE

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 6 a 23 di 23
Titolo Data di pubblicazione Autore(i) File
Does the use of personal electronic health records increase vaccine uptake? A systematic review 1-gen-2020 Balzarini, F.; Frascella, B.; Oradini-Alacreu, A.; Gaetti, G.; Lopalco, P. L.; Edelstein, M.; Azzopardi-Muscat, N.; Signorelli, C.; Odone, A.
Durability of neutralizing antibodies against yellow fever virus after vaccination in healthy adults 1-gen-2023 De Santis, R.; Faggioni, G.; Amoroso, A.; Ciammaruconi, A.; Pomponi, A.; Stella Lia, M.; Amatore, D.; Molinari, F.; Petralito, G.; Stefanelli, P.; Rezza, G.; Lista, F.
Effectiveness of email-based reminders to increase vaccine uptake: a systematic review 1-gen-2020 Frascella, B.; Oradini Alacreu, A.; Balzarini, F.; Signorelli, C.; Lopalco, P. L.; Odone, A.
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 1-gen-2021 Yacoub, Mona-Rita; Cucca, Valentina; Asperti, Chiara; Ramirez, Giuseppe A; Della-Torre, Emanuel; Moro, Matteo; Zandalasini, Camilla; Di Napoli, Davide; Ambrosio, Alberto; Signorelli, Carlo; Colombo, Sergio; Beretta, Luigi; Ciceri, Fabio; Zangrillo, Alberto; Dagna, Lorenzo
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27–45 years of age compared to women 16–26 years of age: An open-label phase 3 study 1-gen-2021 Joura, E. A.; Ulied, A.; Vandermeulen, C.; Rua Figueroa, M.; Seppa, I.; Hernandez Aguado, J. J.; Ahonen, A.; Reich, O.; Virta, M.; Perino, A.; Peris Tuser, M.; Peters, K.; Origoni, M.; Raspagliesi, F.; Tjalma, W. A. A.; Tummers, P.; Woelber, L.; Nieminen, P.; van Damme, P.; Sehouli, J.; Fiol Ruiz, G.; Brucker, S.; Fehm, T.; Cheon, K.; Rawat, S.; Luxembourg, A.; Wittke, F.
The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900–2015 1-gen-2018 Pezzotti, P.; Bellino, S.; Prestinaci, F.; Iacchini, S.; Lucaroni, F.; Camoni, L.; Barbieri, M. M.; Ricciardi, W.; Stefanelli, P.; Rezza, G.
Italy's response to vaccine hesitancy: An innovative and cost effective National Immunization Plan based on scientific evidence 1-gen-2017 Signorelli, C.; Guerra, R.; Siliquini, R.; Ricciardi, W.
Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects 1-gen-2021 Ferrari, D.; Di Resta, C.; Tomaiuolo, R.; Sabetta, E.; Pontillo, M.; Motta, A.; Locatelli, M.
Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy 1-gen-2018 Pezzotti, P.; Miglietta, A.; Neri, A.; Fazio, C.; Vacca, P.; Voller, F.; Rezza, G.; Stefanelli, P.
No jab, no pay and vaccine mandates: Do compulsory policies increase vaccination coverage? The Italian experience 1-gen-2020 Rezza, G.; Ricciardi, W.
Pneumococcal carriage among adults aged 50 years and older with co-morbidities attending medical practices in Rome, Italy 1-gen-2019 Valdarchi, C.; Dorrucci, M.; Mancini, F.; Farchi, F.; Pimentel de Araujo, F.; Corongiu, M.; Ciervo, A.; Rezza, G.; Pantosti, A.; Camilli, R.
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study 1-gen-2023 Fabiani, M.; Mateo-Urdiales, A.; Sacco, C.; Rota, M. C.; Petrone, D.; Bressi, M.; Del Manso, M.; Siddu, A.; Proietti, V.; Battilomo, S.; Menniti-Ippolito, F.; Popoli, P.; Bella, A.; Riccardo, F.; Palamara, A. T.; Rezza, G.; Brusaferro, S.; Pezzotti, P.
Reply to letters to the Editor: Bellavite P. Factors that influenced the historical trends of tetanus and diphtheria. Donzelli A, Duca P. More than 70,000 deaths prevented by vaccination against three diseases in about 75 years? The estimation seems exaggerated 1-gen-2018 Pezzotti, P.; Bellino, S.; Prestinaci, F.; Iacchini, S.; Stefanelli, P.; Rezza, G.
The role of cytotoxic T cells and cytokines in the control of hepatitis B virus infection 1-gen-2002 Guidotti, Luca
Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward 1-gen-2018 Esposito, S.; Principi, N.; Rezza, G.; Bonanni, P.; Gavazzi, G.; Beyer, I.; Sulzner, M.; Celentano, L. P.; Prymula, R.; Rappagliosi, A.; Sevilla, J.; Poland, G.
Vaccine adjuvants: A priority for vaccine research 1-gen-2010 Harandi, Am; Medaglini, D; Shattock, Rj; Working Group convened by, Europrise; Polyanskaya, N; Agger, Em; Bianchi, M; Carter, D; Debre, P; Didierlaurent, A; Gancberg, D; De Gregorio, E; Haensler, J; Kelly, C; Klavinskis, L; Lehner, T; Lindblad, Eb; Lonnroth, A; De Magistris, Mt; Martini, A; Modabber, F; van der Most, R; Nagy, E; Poli, Guido; Romaris, M; Sesardic, D; Vendetti, S; Verrier, B; Wagner, H; Wegmann, F.
Vaccine preventable invasive bacterial diseases in Italy: A comparison between the national surveillance system and recorded hospitalizations, 2007–2016 1-gen-2019 Pezzotti, P.; Bellino, S.; Riccardo, F.; Lucaroni, F.; Cerquetti, M.; Pantosti, A.; Rezza, G.; Stefanelli, P.
When vaccine hesitancy makes headlines 1-gen-2017 Odone, A; Signorelli, C
Mostrati risultati da 6 a 23 di 23
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile